Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep366 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

The effect of tocilizumab – an interleukin-6 receptor antagonist – on lipid levels in rheumatoid arthritis

Kostoglou-Athanassiou Ifigenia , Athanassiou Lambros , Tzanavari Aikaterini , Katsavouni Charoula , Kostopoulos Markos , Pantelidis Dimitrios , Athanassiou Panagiotis

Tocilizumab is an interleukin-6 receptor antagonist used in the treatment of rheumatoid arthritis (RA). It is known to induce remission and inhibit radiographic progression in RA. Tocilizumab may be administered either intravenously or subcutaneously. Its effect on lipid levels and the cardiovascular risk has not been fully investigated. The aim was to study the effect of tocilizumab i.v. on disease activity, lipid levels and cardiovascular risk in RA patients.<p class="ab...

ea0041ep641 | Endocrine tumours and neoplasia | ECE2016

Myelolipoma in a rheumatoid arthritis patient – report of a case

Tzanavari Aikaterini , Kostoglou-Athanassiou Ifigenia , Banti Theodota , Katsavouni Charoula , Xanthakou Eleni , Athanassiou Panagiotis

Introduction: Adrenal myelolipoma is an extremely rare benign adrenal tumor. Adrenal myelolipoma is characterized by the presence within the adrenal gland of mature adipose tissue and active bone marrow elements. Owing to their non-functional nature most cases are incidental, either at autopsy or through computer tomography scan. Occasionally the lesions attain a large size to become clinically apparent. Seropositive rheumatoid arthritis is a disorder affecting approximately 1...

ea0037ep366 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Diabetes mellitus in patients with rheumatoid arthritis

Kostoglou-Athanassiou Ifigenia , Tzanavari Aikaterini , Banti Theodota , Katsavouni Charoula , Kalaycheva Natalia , Athanassiou Panagiotis

Introduction: In rheumatoid arthritis (RA) glucose metabolism may be affected either by the autoimmune inflammatory disease itself, or by the treatment used to manage the disease. Metabolic syndrome seems to be prevalent in RA patients.Aim: The aim was to study the prevalence of diabetes mellitus type 2 and metabolic factors related to the development of atherosclerosis within a cohort of RA patients cared for within a single Rheumatology Department....